Pancreatic Cancer Research

ResearcherZhejiang Provincial People's HospitalActive in the last 2 years

Jun Xia

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3222-2882; OpenAlex author ID A5031659092. Sources: OpenAlex.

Their work

Papers
16 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
20
Papers, trials and grants by year

2012: 3 papers · 2013: 1 paper · 2014: 2 papers · 2015: 2 papers · 2016: 1 paper · 2017: 1 paper · 2018: 1 paper · 2019: 2 papers · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper

Papers 16

  1. FBXO9 promotes anti-tumor immunity via degradation of PD-L1 in pancreatic cancer. Co-author DOI 10.3389/fimmu.2025.1726825↗
  2. FBXO31 is upregulated by METTL3 to promote pancreatic cancer progression via regulating SIRT2 ubiquitination and degradation. Co-author DOI 10.1038/s41419-024-06425-y↗
  3. Glycoproteomic Bioanalysis of Exosomes by LC–MS for Early Diagnosis of Pancreatic Cancer Co-author DOI 10.4155/bio-2021-0036↗
  4. PDS5B regulates cell proliferation and motility via upregulation of Ptch2 in pancreatic cancer cells. Co-author DOI 10.1016/j.canlet.2019.06.014↗
  5. miR-223 Regulates Cell Proliferation and Invasion via Targeting PDS5B in Pancreatic Cancer Cells. Co-author DOI 10.1016/j.omtn.2019.01.009↗
  6. miR-7 Suppresses Tumor Progression by Directly Targeting MAP3K9 in Pancreatic Cancer. Co-author DOI 10.1016/j.omtn.2018.08.012↗
  7. The effects of curcumin on proliferation, apoptosis, invasion, and NEDD4 expression in pancreatic cancer. Co-author DOI 10.1016/j.bcp.2017.05.014↗
  8. Synergistic reversal effect of epithelial-to-mesenchymal transition by miR-223 inhibitor and genistein in gemcitabine-resistant pancreatic cancer cells. Last author PMID 27429851↗
  9. Down-regulation of miR-223 reverses epithelial-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells. Co-author DOI 10.18632/oncotarget.2714↗
  10. N,N'-di-(m-methylphenyi)-3,6-dimethyl-1,4-dihydro-1,2,4,5-tetrazine-1,4-dicarboamide (ZGDHu-1) suppresses the proliferation of PANC-1 pancreatic cancer cells v… First author DOI 10.3892/or.2015.3803↗
  11. Curcumin inhibits cell growth and invasion through up-regulation of miR-7 in pancreatic cancer cells. Co-author DOI 10.1016/j.toxlet.2014.09.014↗
  12. Genistein inhibits cell growth and invasion through regulation of miR-27a in pancreatic cancer cells. Co-author DOI 10.2174/1381612820666140128215756↗
  13. Genistein down-regulates miR-223 expression in pancreatic cancer cells. Co-author DOI 10.2174/13894501113149990187↗
  14. Targeting pancreatic cancer stem cells for cancer therapy. Co-author DOI 10.1016/j.bbcan.2012.06.002↗
  15. Genistein inhibits cell growth and induces apoptosis through up-regulation of miR-34a in pancreatic cancer cells. Co-author DOI 10.2174/138945012804545597↗
  16. Emerging Role of MicroRNA in Pancreatic Cancer. Co-author DOI 10.4172/2165-7092.1000e114↗

Closest collaborators

The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhiwei Peter Wang · 8 shared papers, 2012–2024 · strength 0.68
  2. Jia Ma · 9 shared papers, 2012–2019 · strength 0.55
  3. Jia Ma · 2 shared papers, 2024–2025 · strength 0.42
  4. Tong Cao · 1 shared paper, 2025 · strength 0.23
  5. Hua Huang · 1 shared paper, 2025 · strength 0.23
  6. Yue Cui · 2 shared papers, 2019 · strength 0.21
  7. Shangshang Hu · 1 shared paper, 2024 · strength 0.19
  8. Kai Chen · 1 shared paper, 2024 · strength 0.19
  9. Zhiwei Wang · 4 shared papers, 2012–2016 · strength 0.16
  10. Fazlul H. Sarkar · 4 shared papers, 2012–2013 · strength 0.16
  11. Mingming Xu · 1 shared paper, 2021 · strength 0.15
  12. Shuang Yang · 1 shared paper, 2021 · strength 0.15
  13. Lucio Miele · 3 shared papers, 2012–2013 · strength 0.10
  14. Jingna Su · 1 shared paper, 2017 · strength 0.07
  15. Xuyuan Yin · 1 shared paper, 2017 · strength 0.07
  16. Xiuxia Zhou · 1 shared paper, 2017 · strength 0.07
  17. Yonglie Zhou · 1 shared paper, 2015 · strength 0.05
  18. Su-Feng Chen · 1 shared paper, 2015 · strength 0.05
  19. Sanjeev Banerjee · 1 shared paper, 2012 · strength 0.03
  20. Bin Bao · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.